BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25833456)

  • 1. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.
    Cohen JB; Cohen DL
    Curr Hypertens Rep; 2015 May; 17(5):34. PubMed ID: 25833456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.
    Soltani Z; Washco V; Morse S; Reisin E
    Curr Hypertens Rep; 2015 Feb; 17(2):7. PubMed ID: 25620635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome.
    Chen J; Townsend RR
    Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, inflammation, and kidney disease.
    Navarro-Díaz M; Serra A; López D; Granada M; Bayés B; Romero R
    Kidney Int Suppl; 2008 Dec; (111):S15-8. PubMed ID: 19034319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of increased cardiovascular disease in obesity and metabolic syndrome.
    Vazzana N; Santilli F; Sestili S; Cuccurullo C; Davi G
    Curr Med Chem; 2011; 18(34):5267-80. PubMed ID: 22087824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal markers and predictors, and renal and cardiovascular risk factors].
    Fernández-Andrade C
    Nefrologia; 2002; 22 Suppl 1():2-29. PubMed ID: 11987667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of metabolic syndrome.
    Altabas V
    Curr Clin Pharmacol; 2013 Aug; 8(3):224-31. PubMed ID: 22950955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visceral obesity, hypertension and cardio-renal risk: a review].
    Rosa EC; Zanella MT; Ribeiro AB; Kohlmann Junior O
    Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):196-204. PubMed ID: 16184247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-related cardiovascular risk in children and the role of lifestyle changes.
    Balagopal P
    J Cardiometab Syndr; 2006; 1(4):269-74; quiz 275-6. PubMed ID: 17679806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular consequences of metabolic syndrome.
    Tune JD; Goodwill AG; Sassoon DJ; Mather KJ
    Transl Res; 2017 May; 183():57-70. PubMed ID: 28130064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and chronic kidney disease.
    Eknoyan G
    Nefrologia; 2011; 31(4):397-403. PubMed ID: 21623393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic renal disease in renal transplant patients: management of cardiovascular risk factors.
    Fernández-Fresnedo G; Gómez-Alamillo C; Ruiz JC; de Francisco AL; Arias M
    Transplant Proc; 2009 Jun; 41(5):1637-8. PubMed ID: 19545697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and metabolic syndrome as related to cardiovascular disease.
    Nikolopoulou A; Kadoglou NP
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of albuminuria and the metabolic syndrome.
    Rowley K; O'Dea K; Best JD
    Curr Diab Rep; 2003 Feb; 3(1):80-6. PubMed ID: 12643150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome as a prohypertensive state.
    Mulé G; Cerasola G
    Am J Hypertens; 2008 Jan; 21(1):8. PubMed ID: 18268791
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic syndrome: a marker of patients at high cardiovascular risk.
    Lau DC; Yan H; Dhillon B
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and chronic kidney disease.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Pirulli A; Barazzoni R
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S19-23. PubMed ID: 20797564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension.
    Landsberg L; Aronne LJ; Beilin LJ; Burke V; Igel LI; Lloyd-Jones D; Sowers J
    Obesity (Silver Spring); 2013 Jan; 21(1):8-24. PubMed ID: 23401272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria and chronic kidney disease in association with the metabolic syndrome.
    Ninomiya T; Kiyohara Y
    J Cardiometab Syndr; 2007; 2(2):104-7. PubMed ID: 17684460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.